Implantable Drug Eluting Devices Market
Market Insights on Implantable Drug Eluting Devices covering sales outlook, demand forecast & up-to-date key trends
Implantable Drug Eluting Devices Market by Product (Implantable Drug Infusion Pumps, Intraocular Drug Eluting Devices, Contraceptive Drug Eluting Devices, Buprenorphine Implant, Drug Eluting Stents and Others) & Region - Forecast 2022 - 2029
Implantable Drug Eluting Devices Market Snapshot
[326 Pages Report] Global Implantable Drug Eluting Devices Market is set to experience a significant growth of 6.0% CAGR from 2022 to 2029, with an estimated market value of around US$ 12.8 Bn as of 2022. As per Future Market Insights’ projections, contraceptive drug eluting devices products hold a substantial share of over 39.8% in 2021 within the global market.
|
Data Points |
Market Insights |
|
Market Value 2021 |
US$ 12.1 Bn |
|
Market Value 2022 |
US$ 12.8 Bn |
|
Market Value 2029 |
US$ 19.3 Bn |
|
CAGR 2022-2029 |
6.0% |
|
Market Share of Top 5 Countries |
76.5% |
With the growth in demand for minimally-invasive procedures, implantable drug eluting devices are accumulating a rising range in terms of market penetration, which are established by key market leaders.
Similarly, start-up companies as well as majorly rooted corporations over the globe are working hard to develop novel implantable drug delivery technologies, using wide range of knowledge available in the network which include research institutions, universities, teaching hospitals, and companies.
Due to a massive demand of combination products such as drug eluting devices, major players in the market are adopting competitive strategies such as acquisitions, mergers, as well as collaborations for the development and augmentation of products in the market.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
6.03% |
|
H1, 2022 Projected |
6.00% |
|
H1, 2022 Outlook |
5.90% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 13 ↓ |
According to Future Market Insights’ analysis, the global implantable drug eluting devices market will observe a diminished change in the Basis Point Share (BPS) by nearly 13 BPS in H1- 2022 (O) as compared with H1-2021. The attribute of non-biodegradable implants, which includes the requirement for surgical removal or the accumulation of polymer in the body after usage, has a negative impact on the total market.
Non-biodegradable implants are generally more traumatic to remove than they are to place. This is based on available clinical studies data. The comparative analysis and market growth rate of global implantable drug eluting devices market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 10 BPS.
Furthermore, the manufacture of implants necessitates the use of huge amounts of organic solvent, which might affect drug stability and toxicity, as well as raise environmental problems.
On the contrary, numerous factors present several benefits to the overall implantable drug eluting devices market, including the adoption of compression as a manufacturing technique for implantable drugs, which refrains from the use of heat or solvents, making it a suitable method for manufacture of implants containing heat or solvent sensitive compounds such a proteins or peptides.
This is set to advance the manufacturing capacities of key producers within the global industry space.
Sales Analysis of Implantable Drug Eluting Devices from 2014 to 2021 Vs Market Outlook for 2022 to 2029
The market value for Implantable Drug Eluting Devices holds nearly 5.8% of the overall US$ 208.0 Bn Drug Delivery Devices market in 2021.
Implantable drug eluting devices provide numerous distinctive advantages which include the exceptional prospects of site-specificity, localization and targeted drug delivery process.
The applications of implantable drug eluting devices are indispensable when considered under the scope of cardiology, ophthalmology, birth control, opioid addiction, pain management, diabetes management, contraception, as well as cancer therapy. The targeted drug delivery systems improve the efficacy of treatment (oncology and cardiology) and assists with the reduction of side effects by preventing damage to the healthy tissue.
The implantable drug eluting devices are segmented into two main types: active drug eluting devices and passive drug eluting devices. The technologies essentially incorporated in the active drug eluting devices are electromechanical and osmotic pressure gradient.
Furthermore, the passive drug eluting devices are sub-segmented into 2 types which include biodegradable implants and non-biodegradable implants, wherein, the biodegradable implants are polyester amide and Polylactic glycolic acids devised and the non-biodegradable implantable devices are made using silicon, polyethylene-vinyl acetate and thermoplastic polyurethane.
The non- biodegradable implants possess wide-ranging applications in diabetes, contraception, hormone regulation, pain management, cancer treatment, etc. Implantable drug delivery devices commonly comprise of a drug reservoir enclosed by a polymer or a mixture of a drug polymer.
The implant, when incorporated into the desired, localized area of the body, releases the drug at a pre-calculated rate whilst the polymer degrades. The effective drug delivery system through implantable drug eluting devices is thus set to gain traction in terms of adoption over the forecast period, owing to the specificity of target site and the rate of drug dissolution into the localized area of therapy.
The market is expected to expand at a considerable growth rate over the next seven years at a CAGR of close to 6.0%.
What are the Key Opportunities for Implantable Drug Eluting Devices Manufacturers?
The implantable drug eluting devices is predicted to exhibit a lucrative growth over the forecast period. This growth can be associated with the rising adoption of patient-controlled devices and increasing incidence of peripheral and coronary artery diseases.
Additionally, the key market players are displaying extensive focus on clinical trials of bio-reabsorbable stents and implantable drug infusion pumps. Therefore, the growing adoption by patients and physicians, and rising demand for minimally invasive surgeries are set to offer growth opportunities to key market players in the development of novel implantable drug-eluting devices.
Furthermore, the rising incidence of cardiovascular and chronic diseases over the globe is generating growth opportunities for the global implantable drug eluting devices market. According to the WHO, cardiovascular diseases are one of the major causes of mortality globally.
Several research and clinical studies are currently taking place for the improvement of the functioning of existing drug eluting stents and devices. Research in this area is thus focused on the evaluation and development of novel and augmented drug eluting devices, which uphold notable clinical benefits and eliminate safety concerns regarding their long term application. The innovative efforts in research on next-generation drug eluting devices is expected to further progress procedures such as endothelialization and rapid arterial healing.
These factors are thus comprehensively set to promote the growth of the implantable drug eluting devices market throughout the forecast period.
What are the Factors Restraining Demand for Implantable Drug Eluting Devices?
The factors associated with risks associated with the limited demand and value growth of the implantable drug eluting devices include the process of product recalls, which are indispensable for public health and safety as it leads to voluntary action of manufacturers and distributors to carry out their responsibility that present a risk of injury or defective or gross deception of products.
Additionally, pending approvals of products by regulatory bodies may hinder the growth of injunctions which can restrain the sale of products and may remarkably divert the attention of the management and technical personnel in the market. In the event of approval pending, the company's financial condition, business, and results of operations could be adversely affected.
Moreover, several implantable drug eluting devices pose a problem in terms of patient adherence, in terms of discomfort upon the implants being incorporated to them. The on-going biodegradation of the drug-eluting stents sometimes makes it difficult to maintain the accurate dose at the end of its lifetime. There is always a risk of device failure, which may result in another surgical involvement to correct the device.
Another factor of concern includes the fact that most implants possess an inadequate loading capacity owing to their small size. This gives way to some specific potent medicines for appropriate delivery by implantable devices.
The concerns arising from bodily reaction to a foreign substance also conceives a restrictive growth in the deployment of implants in lieu of its biocompatibility and safety. These factors collectively induce a restraint in the growth of the implantable drug eluting devices market, however, augmented and personalized implant designing may prove to enhance the efficacy of the implanted drug delivery process.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
What Makes the U.S. the Largest Market for Implantable Drug Eluting Devices?
The U.S. dominates the North American region with a total market share of over 94.1% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The vast majority of shares gained by the U.S. in the implantable drug eluting devices market are owed to the factors associated with rising disease burden, increasing geriatric population, and the developing healthcare infrastructure which offers reimbursement opportunities for new procedures.
Why is Germany Considered a Lucrative Market for Implantable Drug Eluting Devices in Europe?
Germany is set to exhibit a CAGR of over 6.2% in the European implantable drug eluting devices market during the forecast period. The lucrative growth in the region is associated with the emergence of key and established players in the country, focusing on research and innovative methodologies for drug delivery and targeted site delivery systems.
What Makes China an Emerging Market for Implantable Drug Eluting Devices?
China holds 46.1% market revenue share in the East Asia market in 2021, and is projected to increase at a CAGR rate of 8.7% during the forecast period. The growth of the implantable drug eluting devices market in the country is attributed to the development of novel drug delivery technologies, such as an implantable nanogenerator, which can be adopted for precise drug delivery system. Furthermore, increasing government funding on research and development activities is set to augment the China implantable drug eluting devices market over the forecast period.
What is the Outlook for Japan Regarding Implantable Drug Eluting Devices?
In 2021, Japan held a 39.3% share in the East Asia implantable drug eluting devices market, and is projected to expand at a CAGR of 8.2% from 2022 to 2029. The growth is associated with the rapid adoption of automated systems in the country, including models for site-specific and targeted drug delivery systems. These augmentations are cost-effective and reduce the error rate during clinical trials.
Category-wise Insights
Which Implantable Drug Eluting Devices Product is Driving Market Growth?
Contraceptive drug eluting devices project a lucrative growth at a CAGR of 6.0% till the end of the forecast period, with a market share of around 39.8% in 2021. The growth is associated with the factor of increasing awareness in terms of female and reproductive health over the globe, and the efforts to minimize the mortality and morbidity rate associated with female reproductive health.
Which Technology is Largely of Focus in the Implantable Drug Eluting Devices Market?
Passive drug eluting device technology holds a revenue share of 96.2% in 2021 and is projected to hold a share over the forecast period with the estimation being 96.6%. The segment holds the maximum revenue share due to the wide ranging applications of passive drug eluting devices in the field of oncology, cardiology, pain management, contraception, etc.
Which Application is Largely of Focus in the Implantable Drug Eluting Devices Market?
Cardiovascular applications hold a revenue share of 45.1% in 2021 and are projected to hold a share over the forecast period with the estimation being 47.3%. The segment gains traction with the rising incidence of chronic diseases and the risks associated with infectious agents among the geriatric population.
Which Implantation Type Holds a Dominant Stance in the Global Implantable Drug Eluting Devices Market?
Intravascular implantation type hold a revenue share of 44.1% in 2021 and is projected to hold a share over the forecast period with the estimation being 46.1%. The extensive ranging applications of the intravascular implants as well as the efficient patient adherence and outcomes have contributed to this method as being implemented widely across several treatment indications.
Which End User Holds a Dominant Stance in the Global Implantable Drug Eluting Devices Market?
Hospitals hold a revenue share of 61.9% in 2021 and are projected to hold a share over the forecast period with the estimation being 66.0%. The process of targeted drug delivery through implantable drug eluting devices requires the aid of skilled physicians with patient data for close monitoring in the event of implant rejection or other adverse events. Thus, the hospitals segment accounts for a massive share in the implantable drug eluting devices market.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Corporate tie-ups amongst implantable drug eluting devices manufacturers, acquisitions, expansion, product launches, agreements and increasing clinical trials and research activities are the key strategies adopted by manufacturers to increase the product sales in different geographies.
- In August 2021, Medtronic plc announced that it has entered into a definitive agreement with Intersect ENT a global medical technology leader dedicated to transforming patient care, in which Medtronic will acquire all outstanding shares of Intersect ENT.
- In March 2020, Allergan received FDA approval for DURYSTA™ (bimatoprost implant) the first and only Intracameral Biodegradable Sustained-Release implant to lower intraocular pressure in Open-Angle Glaucoma or Ocular Hypertension Patients.
Similarly, recent developments related to companies operating in the implantable drug eluting devices market have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope as per Implantable Drug Eluting Devices Market Analysis
|
Attribute |
Details |
|
Forecast Period |
2022-2029 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, and GCC Countries, Northern Africa, South Africa, Turkey |
|
Key Market Segments Covered |
Product, Technology, Application, Implantation Type, End User and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered in Implantable Drug Eluting Devices Industry Research
By Product:
- Implantable Drug Infusion Pumps
- Intraocular Drug Eluting Devices
- Contraceptive Drug Eluting Devices
- Buprenorphine Implant
- Drug Eluting Stents
- Others
By Technology:
- Active Drug Eluting Device
- Passive Drug Eluting Device
- Biodegradable Implants
- Non-Biodegradable Implants
By Application:
- Diabetic Macular Edema
- Birth Control/Contraception
- Opioid Addiction
- Cardiovascular
- Ophthalmology
- Oncology
- Pain Management
By Implementation Type:
- Intravaginal
- Intravascular
- Intraocular
- Intrathecal
- Subcutaneous
- Intrauterine
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Optical Care Centers
- Cardiac Surgery Centers
- Office Based Settings
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
How much is the Implantable Drug Eluting Devices market currently worth?
The global implantable drug eluting devices market is worth US$ 12.1 Bn at present, and is set to expand 1.5 X over the next seven years.
What is the sales forecast for Implantable Drug Eluting Devices through 2029?
The implantable drug eluting devices market is expected to reach US$ 19.3 Bn by the end of 2029, with sales revenue expected to register 6.0% CAGR.
What are the key trends shaping the Implantable Drug Eluting Devices industry?
Growing research collaborations and distribution of implantable drug eluting devices by key market leaders, new product launches and government initiatives are some of the key trends being witnessed in this marketplace.
Which are the top 5 countries driving demand for Implantable Drug Eluting Devices?
The U.S, Germany, U.K, France and China are expected to drive demand in implantable drug eluting devices market.
What is the North America market outlook for Implantable Drug Eluting Devices?
North America is one of the key markets for implantable drug eluting devices, with the U.S. expected to account over 95.3% of the North American market during the forecast period.
At what percentage is the demand for Implantable Drug Eluting Devices expected to register growth in Europe?
Demand for implantable drug eluting devices in Europe is expected to register growth of 4.9% over the next seven years.
Which countries are key producers of Implantable Drug Eluting Devices products?
The U.S., U.K. and Germany are key producers of implantable drug eluting devices products.
Which are the key exporters of Implantable Drug Eluting Devices market?
Pfizer Inc., Medtronic Inc., Merck & Co. In, Bayer AG, JOHNSON & JOHNSON, SurModics Inc., AstraZeneca Plc., Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, INC., Abbott Laboratories, Allergan, Inc., Bausch and Lomb, Inc., Alimera Sciences, and REVA Medical, Inc. are the key exporters of implantable drug eluting devices market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion & Exclusion/ Scope of the Report 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Development Trends 4. Key Success Factors 4.1. New Product Launches & Regulatory Approvals 4.2. Key Strategies Followed By Manufacturers 5. Market Context 5.1. Product Adoption / Application Analysis 5.2. Regulatory Scenario 5.3. Value Chain Analysis 5.4. Reimbursement Scenario 6. Global Market Demand Analysis 2014-2021 and Forecast, 2022-2029 6.1. Historical Market Volume (Units) Analysis, 2014-2021 6.2. Current and Future Market Volume (Units) Projections, 2021-2029 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029 8.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Market Background 9.1. Macro-Economic Factors 9.1.1. Global GDP Growth Outlook 9.1.2. Global Healthcare Outlook 9.1.3. Per Capita Healthcare Expenditure Outlook 9.2. Forecast Factors - Relevance & Impact 9.3. Market Dynamics 9.3.1. Drivers 9.3.2. Restraints 9.3.3. Opportunity Analysis 10. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Technology 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014 - 2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022 – 2029 10.3.1. Active Drug Eluting Device 10.3.2. Passive Drug Eluting Device 10.3.2.1. Biodegradable implants 10.3.2.2. Non-biodegradable implants 10.4. Market Attractiveness Analysis By Technology 11. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Product 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Product, 2014 - 2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022 - 2029 11.3.1. Implantable Drug Infusion Pumps 11.3.2. Intraocular Drug Eluting Devices 11.3.3. Contraceptive Drug Eluting Devices 11.3.4. Buprenorphine Implant 11.3.5. Drug-Eluting Stents 11.3.6. Others 11.4. Market Attractiveness Analysis By Product 12. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By Application, 2014 - 2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 - 2029 12.3.1. Diabetic Macular Edema 12.3.2. Birth Control/Contraception 12.3.3. Opioid Addiction 12.3.4. Cardiovascular 12.3.5. Ophthalmology 12.3.6. Oncology 12.3.7. Pain Management 12.4. Market Attractiveness Analysis By Application 13. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Implantation Type 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Analysis By Implantation Type, 2014 - 2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Implantation Type, 2022 - 2029 13.3.1. Intravaginal 13.3.2. Intravascular 13.3.3. Intraocular 13.3.4. Intrathecal 13.3.5. Subcutaneous 13.3.6. Intrauterine 13.4. Market Attractiveness Analysis By Implantation Type 14. Global Market Analysis 2014-2021 and Forecast 2022-2029, by End User 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2029 14.3.1. Hospitals 14.3.2. Ambulatory Surgical Centres 14.3.3. Optical Care Centres 14.3.4. Cardiac Surgery Centres 14.3.5. Office based settings 14.3.6. Others 14.4. Market Attractiveness Analysis By End User 15. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Region 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2021 15.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029 15.3.1. North America 15.3.2. Latin America 15.3.3. Europe 15.3.4. Middle East and Africa (MEA) 15.3.5. East Asia 15.3.6. South Asia 15.3.7. Oceania 15.4. Market Attractiveness Analysis By Region 16. North America Market Analysis 2014-2021 and Forecast 2022-2029 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 16.3.1. By Country 16.3.1.1. U.S. 16.3.1.2. Canada 16.3.2. By Technology 16.3.3. By Product 16.3.4. By Application 16.3.5. By Implantation Type 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Technology 16.4.3. By Product 16.4.4. By Application 16.4.5. By Implantation Type 16.4.6. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Latin America Market Analysis 2014-2021 and Forecast 2022-2029 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 17.3.1. By Country 17.3.1.1. Brazil 17.3.1.2. Mexico 17.3.1.3. Rest of Latin America 17.3.2. By Technology 17.3.3. By Product 17.3.4. By Application 17.3.5. By Implantation Type 17.3.6. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Technology 17.4.3. By Product 17.4.4. By Application 17.4.5. By Implantation Type 17.4.6. By End User 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Europe Market Analysis 2014-2021 and Forecast 2022-2029 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 18.3.1. By Country 18.3.1.1. Germany 18.3.1.2. Italy 18.3.1.3. France 18.3.1.4. U.K. 18.3.1.5. Spain 18.3.1.6. BENELUX 18.3.1.7. Russia 18.3.1.8. Rest of Europe 18.3.2. By Technology 18.3.3. By Product 18.3.4. By Application 18.3.5. By Implantation Type 18.3.6. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Technology 18.4.3. By Product 18.4.4. By Application 18.4.5. By Implantation Type 18.4.6. By End User 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. South Asia Market Analysis 2014-2021 and Forecast 2022-2029 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 19.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Thailand 19.3.1.3. Indonesia 19.3.1.4. Malaysia 19.3.1.5. Rest of South Asia 19.3.2. By Technology 19.3.3. By Product 19.3.4. By Application 19.3.5. By Implantation Type 19.3.6. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Technology 19.4.3. By Product 19.4.4. By Application 19.4.5. By Implantation Type 19.4.6. By End User 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. East Asia Market Analysis 2014-2021 and Forecast 2022-2029 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 20.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 20.3.1. By Country 20.3.1.1. China 20.3.1.2. Japan 20.3.1.3. South Korea 20.3.2. By Technology 20.3.3. By Product 20.3.4. By Application 20.3.5. By Implantation Type 20.3.6. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Technology 20.4.3. By Product 20.4.4. By Application 20.4.5. By Implantation Type 20.4.6. By End User 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 21. Oceania Market Analysis 2014-2021 and Forecast 2022-2029 21.1. Introduction 21.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 21.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 21.3.1. By Country 21.3.1.1. Australia 21.3.1.2. New Zealand 21.3.2. By Technology 21.3.3. By Product 21.3.4. By Application 21.3.5. By Implantation Type 21.3.6. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Technology 21.4.3. By Product 21.4.4. By Application 21.4.5. By Implantation Type 21.4.6. By End User 21.5. Key Market Participants - Intensity Mapping 21.6. Drivers and Restraints - Impact Analysis 22. Middle East and Africa Market Analysis 2014-2021 and Forecast 2022-2029 22.1. Introduction 22.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2021 22.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 22.3.1. By Country 22.3.1.1. GCC Countries 22.3.1.2. Turkey 22.3.1.3. Northern Africa 22.3.1.4. South Africa 22.3.1.5. Rest of Middle East and Africa 22.3.2. By Technology 22.3.3. By Product 22.3.4. By Application 22.3.5. By Implantation Type 22.3.6. By End User 22.4. Market Attractiveness Analysis 22.4.1. By Country 22.4.2. By Technology 22.4.3. By Product 22.4.4. By Application 22.4.5. By Implantation Type 22.4.6. By End User 22.5. Key Market Participants - Intensity Mapping 22.6. Drivers and Restraints - Impact Analysis 23. Emerging Countries Market Analysis 2014-2021 and Forecast 2022-2029 23.1. Introduction 23.1.1. Market Value Proportion Analysis, By Key Countries 23.1.2. Global Vs. Country Growth Comparison 23.2. China Market Analysis 23.2.1. Introduction 23.2.2. Market Value Proportion Analysis by Market Taxonomy 23.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 23.2.3.1. By Technology 23.2.3.2. By Product 23.2.3.3. By Application 23.2.3.4. By Implantation Type 23.2.3.5. By End User 23.2.4. China Market - Competition Landscape 23.3. India Market Analysis 23.3.1. Introduction 23.3.2. Market Value Proportion Analysis by Market Taxonomy 23.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 23.3.3.1. By Technology 23.3.3.2. By Product 23.3.3.3. By Application 23.3.3.4. By Implantation Type 23.3.3.5. By End User 23.3.4. India Market - Competition Landscape 23.4. Brazil Market Analysis 23.4.1. Introduction 23.4.2. Market Value Proportion Analysis by Market Taxonomy 23.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 23.4.3.1. By Technology 23.4.3.2. By Product 23.4.3.3. By Application 23.4.3.4. By Implantation Type 23.4.3.5. By End User 23.4.4. Brazil Market - Competition Landscape 24. Market Structure Analysis 24.1. Market Structure Analysis by Tier of Companies 24.2. Market Share Analysis 24.3. Market Concentration 24.4. Market Presence Analysis 24.4.1. By Regional footprint of Players 24.4.2. Product foot print by Players 24.4.3. Channel Foot Print by Players 25. Competition Analysis 25.1. Competition Dashboard 25.2. Competition Deep Dive 25.2.1. Pfizer Inc. 25.2.1.1. Overview 25.2.1.2. Product Portfolio 25.2.1.3. Profitability by Market segment 25.2.1.4. Sales Footprint 25.2.1.5. Strategy Overview 25.2.1.5.1. Marketing Strategy 25.2.1.5.2. Product Strategy 25.2.1.5.3. Channel Strategy 25.2.2. Medtronic Inc. 25.2.2.1. Overview 25.2.2.2. Product Portfolio 25.2.2.3. Profitability by Market segment 25.2.2.4. Sales Footprint 25.2.2.5. Strategy Overview 25.2.2.5.1. Marketing Strategy 25.2.2.5.2. Product Strategy 25.2.2.5.3. Channel Strategy 25.2.3. Merck & Co., In 25.2.3.1. Overview 25.2.3.2. Product Portfolio 25.2.3.3. Profitability by Market segment 25.2.3.4. Sales Footprint 25.2.3.5. Strategy Overview 25.2.3.5.1. Marketing Strategy 25.2.3.5.2. Product Strategy 25.2.3.5.3. Channel Strategy 25.2.4. Bayer AG 25.2.4.1. Overview 25.2.4.2. Product Portfolio 25.2.4.3. Profitability by Market segment 25.2.4.4. Sales Footprint 25.2.4.5. Strategy Overview 25.2.4.5.1. Marketing Strategy 25.2.4.5.2. Product Strategy 25.2.4.5.3. Channel Strategy 25.2.5. Johnson & Johnson 25.2.5.1. Overview 25.2.5.2. Product Portfolio 25.2.5.3. Profitability by Market segment 25.2.5.4. Sales Footprint 25.2.5.5. Strategy Overview 25.2.5.5.1. Marketing Strategy 25.2.5.5.2. Product Strategy 25.2.5.5.3. Channel Strategy 25.2.6. SurModics Inc. 25.2.6.1. Overview 25.2.6.2. Product Portfolio 25.2.6.3. Profitability by Market segment 25.2.6.4. Sales Footprint 25.2.6.5. Strategy Overview 25.2.6.5.1. Marketing Strategy 25.2.6.5.2. Product Strategy 25.2.6.5.3. Channel Strategy 25.2.7. AstraZeneca Plc. 25.2.7.1. Overview 25.2.7.2. Product Portfolio 25.2.7.3. Profitability by Market segment 25.2.7.4. Sales Footprint 25.2.7.5. Strategy Overview 25.2.7.5.1. Marketing Strategy 25.2.7.5.2. Product Strategy 25.2.7.5.3. Channel Strategy 25.2.8. Boston Scientific Corporation 25.2.8.1. Overview 25.2.8.2. Product Portfolio 25.2.8.3. Profitability by Market segment 25.2.8.4. Sales Footprint 25.2.8.5. Strategy Overview 25.2.8.5.1. Marketing Strategy 25.2.8.5.2. Product Strategy 25.2.8.5.3. Channel Strategy 25.2.9. Titan Pharmaceuticals, Inc. 25.2.9.1. Overview 25.2.9.2. Product Portfolio 25.2.9.3. Profitability by Market segment 25.2.9.4. Sales Footprint 25.2.9.5. Strategy Overview 25.2.9.5.1. Marketing Strategy 25.2.9.5.2. Product Strategy 25.2.9.5.3. Channel Strategy 25.2.10. BIOTRONIK, INC. 25.2.10.1. Overview 25.2.10.2. Product Portfolio 25.2.10.3. Profitability by Market segment 25.2.10.4. Sales Footprint 25.2.10.5. Strategy Overview 25.2.10.5.1. Marketing Strategy 25.2.10.5.2. Product Strategy 25.2.10.5.3. Channel Strategy 25.2.11. Abbott Laboratories 25.2.11.1. Overview 25.2.11.2. Product Portfolio 25.2.11.3. Profitability by Market segment 25.2.11.4. Sales Footprint 25.2.11.5. Strategy Overview 25.2.11.5.1. Marketing Strategy 25.2.11.5.2. Product Strategy 25.2.11.5.3. Channel Strategy 25.2.12. Allergan, Inc. 25.2.12.1. Overview 25.2.12.2. Product Portfolio 25.2.12.3. Profitability by Market segment 25.2.12.4. Sales Footprint 25.2.12.5. Strategy Overview 25.2.12.5.1. Marketing Strategy 25.2.12.5.2. Product Strategy 25.2.12.5.3. Channel Strategy 25.2.13. Bausch and Lomb, Inc. 25.2.13.1. Overview 25.2.13.2. Product Portfolio 25.2.13.3. Profitability by Market segment 25.2.13.4. Sales Footprint 25.2.13.5. Strategy Overview 25.2.13.5.1. Marketing Strategy 25.2.13.5.2. Product Strategy 25.2.13.5.3. Channel Strategy 25.2.14. Alimera Sciences 25.2.14.1. Overview 25.2.14.2. Product Portfolio 25.2.14.3. Profitability by Market segment 25.2.14.4. Sales Footprint 25.2.14.5. Strategy Overview 25.2.14.5.1. Marketing Strategy 25.2.14.5.2. Product Strategy 25.2.14.5.3. Channel Strategy 25.2.15. REVA Medical, Inc. 25.2.15.1. Overview 25.2.15.2. Product Portfolio 25.2.15.3. Profitability by Market segment 25.2.15.4. Sales Footprint 25.2.15.5. Strategy Overview 25.2.15.5.1. Marketing Strategy 25.2.15.5.2. Product Strategy 25.2.15.5.3. Channel Strategy 26. Assumptions and Acronyms Used 27. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Volume (in Units) Analysis 2014-2021 and Forecast 2022-2029, By Region Table 02: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region Table 03: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 04: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 05: Global Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 06: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 07: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 08: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 09: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 10: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 11: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 12: North America Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 13: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 14: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 15: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 16: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 17: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 18: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 19: Latin America Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 20: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 21: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 22: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 23: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 24: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 25: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 26: Europe Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 27: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 28: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 29: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 30: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 31: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 32: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 33: East Asia Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 34: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 35: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 36: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 37: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 38: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 39: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 40: South Asia Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 41: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 42: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 43: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 44: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 45: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 46: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 47: Oceania Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 48: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 49: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 50: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 51: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 52: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 53: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 54: Middle East and Africa Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 55: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 56: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 57: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 58: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 59: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 60: China Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 61: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 62: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 63: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 64: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 65: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 66: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 67: India Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 68: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 69: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 70: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 71: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Table 72: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 73: India Market Size Volume (Units) Analysis 2014-2021 and Forecast 2022-2029, By Product Table 74: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Table 75: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Table 76: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value Share, by Product (2022E) Figure 02: Global Market Value Share, by Technology (2022E) Figure 03: Global Market Value Share, by Implantation Type (2022E) Figure 04: Global Market Value Share, by Application (2022E) Figure 05: Global Market Value Share, by End User (2022E) Figure 06: Global Market Value Share, by Region (2022E) Figure 07: Global Market Size (US$ Mn) Analysis, 2014–2021 Figure 08: Global Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022–2029 Figure 09: Global Market Absolute $ Opportunity Analysis, 2022–2029 Figure 10: Global Market Volume (in Units) Analysis, 2014–2021 Figure 11: Global Market Volume (in Units) & Y-o-Y Growth (%) Analysis, 2022–2029 Figure 12: Global Market Analysis by Region –2022 & 2029 Figure 13: Global Market Y-o-Y Growth Projections by Region, 2022 – 2029 Figure 14: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region Figure 15: Global Market Analysis by Technology –2022 & 2029 Figure 16: Global Market Y-o-Y Growth Projections by Technology, 2022 – 2029 Figure 17: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 18: Global Market Analysis by Product –2022 & 2029 Figure 19: Global Market Y-o-Y Growth Projections by Product, 2022 – 2029 Figure 20: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 21: Global Market Analysis by Application –2022 & 2029 Figure 22: Global Market Y-o-Y Growth Projections by Application, 2022 – 2029 Figure 23: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 24: Global Market Analysis by Implantation Type –2022 & 2029 Figure 25: Global Market Y-o-Y Growth Projections by Implantation Type, 2022 – 2029 Figure 26: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 27: Global Market Analysis by End User –2022 & 2029 Figure 28: Global Market Y-o-Y Growth Projections by End User, 2022 – 2029 Figure 29: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 30:North America Market Size (US$ Mn) Analysis, 2014-2021 Figure 31: North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 32: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 33: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 34: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 35: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 36: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 37: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 38:Latin America Market Size (US$ Mn) Analysis, 2014-2021 Figure 39: Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 40: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 41: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 42: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 43: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 44: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 45: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 46:Europe Market Size (US$ Mn) Analysis, 2014-2021 Figure 47: Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 48: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 49: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 50: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 51: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 52: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 53: Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 54:East Asia Market Size (US$ Mn) Analysis, 2014-2021 Figure 55: East Asia Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 56: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 57: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 58: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 59: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 60: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 61: East Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 62:South Asia Market Size (US$ Mn) Analysis, 2014-2021 Figure 63: South Asia Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 64: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 65: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 66: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 67: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 68: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 69: South Asia Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 70:Oceania Market Size (US$ Mn) Analysis, 2014-2021 Figure 71: Oceania Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 72: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 73: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 74: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 75: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 76: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 77: Oceania Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 78:Middle East and Africa Market Size (US$ Mn) Analysis, 2014-2021 Figure 79: Middle East and Africa Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 80: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Figure 81: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 82: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 83: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 84: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 85: Middle East and Africa Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 86:China Market Size (US$ Mn) Analysis, 2014-2021 Figure 87: China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 88: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 89: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 90: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 91: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 92: China Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 93:India Market Size (US$ Mn) Analysis, 2014-2021 Figure 94: India Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 95: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 96: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 97: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 98: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 99: India Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology Figure 100:Brazil Market Size (US$ Mn) Analysis, 2014-2021 Figure 101: Brazil Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 102: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Figure 103: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Implantation Type Figure 104: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application Figure 105: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Figure 106: Brazil Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Technology
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
